title: EAU guidelines on testicular cancer: 2011 update.
abstract: BACKGROUND
  On behalf of the European Association of Urology (EAU), guidelines for the diagnosis, therapy, and follow-up of testicular cancer were established.
  
  
  OBJECTIVE
  This article is a short version of the EAU testicular cancer guidelines and summarises the main conclusions from the guidelines on the management of testicular cancer.
  
  
  METHODS
  Guidelines were compiled by a multidisciplinary guidelines working group. A systematic review was carried out using Medline and Embase, also taking Cochrane evidence and data from the European Germ Cell Cancer Consensus Group into consideration. A panel of experts weighted the references, and a level of evidence and grade of recommendation were assigned.
  
  
  RESULTS
  There is a paucity of literature especially regarding longer term follow-up, and results from a number of ongoing trials are awaited. The choice of treatment centre is of the utmost importance, and treatment in reference centres within clinical trials, especially for poor-prognosis nonseminomatous germ cell tumours, provides better outcomes. For patients with clinical stage I seminoma, based on recently published data on long-term toxicity, adjuvant radiotherapy is no longer recommended as first-line adjuvant treatment. The TNM classification 2009 is recommended.
  
  
  CONCLUSIONS
  These guidelines contain information for the standardised management of patients with testicular cancer based on the latest scientific insights. Cure rates are generally excellent, but because testicular cancer mainly affects men in their third or fourth decade of life, treatment effects on fertility require careful counselling of patients, and treatment must be tailored taking individual circumstances and patient preferences into account.
authors.affiliation: Department of Urology, Düsseldorf University, Düsseldorf, Germany. Peter.Albers@med.uni-duesseldorf.de
authors.forename: Peter
authors.initials: P
authors.lastname: Albers
authors.forename: Walter
authors.initials: W
authors.lastname: Albrecht
authors.forename: Ferran
authors.initials: F
authors.lastname: Algaba
authors.forename: Carsten
authors.initials: C
authors.lastname: Bokemeyer
authors.forename: Gabriella
authors.initials: G
authors.lastname: Cohn-Cedermark
authors.forename: Karim
authors.initials: K
authors.lastname: Fizazi
authors.forename: Alan
authors.initials: A
authors.lastname: Horwich
authors.forename: Maria Pilar
authors.initials: MP
authors.lastname: Laguna
mesh_terms: D000328:Adult; D005060:Europe; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011379:Prognosis; D012955:Societies, Medical / Q000592:standards*; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D014572:Urology / Q000592:standards*